Symposium - Perspectives on Depression and Diabetes
Time:11:15 am - 1:00 pm
Location:Room 5 - San Diego Convention Center
Melissa Wellons, M.D. (Chair), University of Alabama at Birmingham
Elizabeth Barrett-Conner, M.D., University of California San Diego
Claudio N. Soares, M.D., Ph.D., McMaster University
Needs Assessment and Description
The U.S. Census Bureau estimates that by 2050, half of U.S.
women will be age 45 or older. Based on 2008 data from
the Centers for Disease Control and Prevention (CDC), 20%
of all women have been diagnosed with depression in their
lifetime. The proportion is higher for women ages 45-54.
Also, based on CDC projections, a girl born in the year 2000
(i.e., a 50-year-old woman in 2050) has a 30% lifetime risk
of developing diabetes if she is white and a 50% risk if she
identifies with a racial/ethnic minority group. This live course
will educate healthcare professionals on depression and
diabetes, and the relationship between them, in order to
improve care to women in their practices.
At the conclusion of this session, participants should be able
- Describe the observed relationship between endogenous
hormone levels and risk of diabetes in postmenopausal
women not treated with sex steroid hormone therapy.
- Discuss the observed relationship between exogenous sex
steroid hormone therapy and risk of diabetes.
- Explain the possible interactive effects of sex steroid
hormones on mood and diabetes development.
A 48-year-old woman presents to your clinic with complaints
of early morning awakenings with a lack of refreshing sleep,
increased appetite and a loss of sexual desire over the past
5 months. Her last menstrual period was 2 months ago but
they had been occurring every 21-30 days for the 8 months
prior to her last menses. Her medical history is significant for a
diagnosis of “pre-diabetes” based on a hemoglobin A1C of
6.0 measured 6 months ago. Her family history is significant
for diabetes in her father. After participating in this session, in
my practice I will talk with this patient about:
- How depression may influence the development of
diabetes and vice-versa.
- Why women with pre-diabetes should take testosterone
therapy to prevent the development of overt diabetes.
- Why she should consider bilateral ovarian removal.
- Not applicable to my area of practice.